Houston Texans wide receiver John Metchie III missed his rookie season in the NFL after being diagnosed with acute promyelocytic leukemia. On Sunday, the former Alabama standout scored his first NFL ...

Metchie, who announced he was diagnosed with APL (acute promyelocytic leukemia) in 2022, has worked his way back to playing ...

A second-round draft choice from Alabama in 2022, wide receiver John Metchie III scored his first NFL touchdown on Sunday ...

He became a second-round draft pick for Houston and hopefully the long-term option in the slot. He underwent a battle with ...

a first-in-class oral selective RARα agonist in RARA-positive patients with higher-risk myelodysplastic syndrome and acute ...

Fintel reports that on November 13, 2024, JMP Securities downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...

The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia ... Radon, Even at Levels Below EPA Guideline for Mitigation, Is Linked to Childhood Leukemia ...

He got checked out, and in July was given a shocking diagnosis: acute promyelocytic leukemia. Suddenly, his budding football ...

AF is a 35-year-old female patient who is on day 5 of her chemotherapy regimen for a diagnosis of acute promyelocytic leukemia (APL). She initially received oral tretinoin (Vesanoid) followed by ...

It hasn’t been an easy voyage to the top levels of his sport for John Metchie III. During an outstanding college football ...

With five catches, including his first touchdown since he starred at Alabama, the wide receiver had his best day as a pro ...

Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...